The paradox is stark: while UK business insolvencies have climbed to their highest level since 2012, the human health sector is posting robust growth. New analysis of Office for National Statistics (ONS) data by LegalVision reveals a 4.78% net expansion in the health sector between 2022 and 2024—a counterintuitive beacon for founders navigating economic headwinds. Meanwhile, Hackney leads all UK regions with business failures at 3.44%, suggesting opportunity and risk are distributed unevenly across the country.

This divergence presents a crucial insight for early-stage operators and startup founders: when the economy contracts, some sectors don't just survive—they flourish. Understanding why, and where, is essential strategic intelligence.

The Scale of UK Business Failures in 2026

Business insolvencies across the UK have reached levels not seen since the post-2008 financial crisis stabilised. According to the latest data, company liquidations and administrations are accelerating, driven by persistent inflation, rising energy costs, and high interest rates constraining cash flow for overleveraged SMEs.

The Office for National Statistics reported that company insolvencies in England, Wales, and Northern Ireland reached their highest quarterly volume in over a decade. For founders, this backdrop creates both competition (fewer rivals) and opportunity (market consolidation, asset acquisition, and talent mobility).

Hackney, a London borough with a dense population of creative agencies, hospitality businesses, and light manufacturing, has emerged as a regional failure hotspot. The 3.44% business failure rate there reflects the postcode lottery of UK recovery—London's east end remains vulnerable to sector-specific shocks (hospitality, retail), while tech and professional services hubs show resilience.

Understanding regional variation is critical. A founder in Hackney launching a B2B SaaS startup faces different headwinds than one in Cambridge or Bristol, where venture density and white-collar employment are higher.

Why Health Sector Growth Defies Downturns

The human health sector—encompassing private medical practice, dentistry, physiotherapy, mental health services, and specialist clinics—expanded at 4.78% net growth over the 2022-2024 period. This growth is no accident; it is structural and policy-driven.

The primary driver is the NHS waiting list crisis. As of mid-2026, NHS waiting times for routine procedures have extended dramatically. Non-emergency procedures now face waits of 18+ months in many regions; diagnostic imaging backlogs stretch to over a year. This capacity crisis has created an explicit market opportunity for private providers.

Private healthcare utilisation has surged. According to the Independent Healthcare Sector Association, private medical consultations rose 34% year-on-year in 2024-2025, and private surgical procedures increased by 28%. Self-paying patients, plus those with private health insurance (employers expanding coverage to offset NHS delays), are funding clinic expansion across England.

Founders entering this space benefit from several tailwinds:

• Regulatory stability: The Care Quality Commission (CQC) provides clear registration pathways for independent practitioners and clinics. Compliance is rigorous but predictable.
• Reimbursement certainty: Private patients pay directly or via insurer; no government budget cuts, unlike NHS contract volatility.
• Digital adoption lag: Many private practices still operate on paper records and fragmented booking systems, creating scope for health tech startups.
• Specialist clustering: London, Manchester, and Bristol have dense private clinic networks, lowering customer acquisition costs for complementary services (diagnostics, admin software, supply chain).

The demographic backdrop reinforces this. An ageing UK population is driving demand for chronic disease management, physiotherapy, and preventative care—services private providers are positioned to deliver faster than the NHS.

Hackney: A Case Study in Regional Divergence

Hackney's 3.44% business failure rate warrants closer examination, as it illustrates why sector and geography matter as much as macroeconomics.

Hackney has a high concentration of hospitality, independent retail, and creative agencies—sectors that have been under structural pressure. Hospitality businesses face sustained labour shortages and rising energy bills; independent retailers compete with e-commerce and mall consolidation; creative agencies are consolidating as clients pursue in-house capabilities or larger generalist shops.

Yet Hackney also has a thriving health services cluster. The borough is home to multiple independent clinics, dental practices, and physiotherapy providers. These are not failing; they are expanding. This microcosm reveals a key principle: failure and growth are sector-specific, not postcode-specific.

For founders evaluating location, Hackney offers both lessons and opportunities. The postcode has lower commercial rent than central London, strong transport links (Overground, bus networks), and a large population. For a health tech founder or clinic operator, Hackney offers good unit economics and customer density. For a traditional retail or hospitality operator, the headwinds are steeper.

Regional variation also reflects regulatory support. The North West has benefited from regional development agency investment and NHS partnerships; the Midlands has attracted life sciences clusters around universities; Hackney's growth in health is partly driven by nearby teaching hospitals (St Bartholomew's, Royal London) creating referral pathways and talent pools.

NHS Wait Times: The Silent Engine of Private Growth

The link between NHS capacity constraints and private sector expansion is direct and quantifiable. As NHS waiting times have extended, private healthcare has absorbed demand elastically.

NHS England's own data shows that by mid-2026, approximately 7.5 million patients are waiting for treatment. A significant cohort of these—estimate 15-20% based on IHSA analysis—have either already moved to private care or are actively considering it. This is not trivial; it represents a multi-billion-pound market reallocation from public to private.

For elective surgery, the divergence is extreme. An NHS patient needing a hip replacement might wait 2+ years; a private patient can access surgery within weeks. Diagnostic imaging (MRI, CT scans) shows similar patterns. This is driving both self-pay demand and employer-funded insurance expansion.

Entrepreneurs should note: this is not a temporary anomaly. NHS structural capacity deficits are forecast to persist for 5+ years. Waiting lists are expected to grow before they shrink, given population ageing and demand growth outpacing NHS funding. Private providers expanding now are investing in secular growth, not cyclical recovery.

Opportunities for Health-Focused Founders

The 4.78% health sector growth rate masks considerable sub-sector variation. Some areas are saturated (high-street general practice); others are undersupplied (diagnostics, mental health, workplace wellness).

Clinical Services: Independent physiotherapy, dentistry, and optometry practices are expanding rapidly. Many are small, owner-operated, and lack professional management systems. This creates acquisition and roll-up opportunities for founders with operational discipline and capital access.

Health Tech and Admin Infrastructure: Private clinics operate on legacy booking and billing systems. SaaS founders building appointment management, patient records, and billing software tailored to independent practitioners can capture high LTV, low CAC revenue. Companies House filings show dozens of health tech startups raising capital in this space.

Diagnostic Services: Independent diagnostic centres (ultrasound, bloods, imaging) are undersupplied relative to demand. Low regulatory barriers to entry (CQC registration, equipment capex) attract entrepreneurs; high margins (cash pay patients, insurance reimbursement) justify investment.

Workplace Wellness and Occupational Health: Employers are investing in on-site and near-site clinics to manage employee health and reduce sick leave. This B2B2C model is nascent but growing rapidly.

Regulatory and Financing Landscape

For health entrepreneurs, understanding the regulatory and financing environment is essential.

Registration: Most clinical services require CQC registration. The CQC publishes clear guidance and timelines; registration typically takes 2-3 months and costs £1,500-£4,000 depending on service type. This is a low barrier relative to other regulated sectors (e.g., financial services).

Professional Indemnity Insurance: Essential for any clinical service provider. Costs vary (£1,000-£10,000+ annually) based on service type and claims history. Factor this into early unit economics.

Funding: Health startups are attractive to impact investors, healthcare-focused VCs, and traditional equity investors. SEIS/EIS tax relief (described in detail at gov.uk) applies to qualifying health startups, making them tax-efficient for angel investors. Innovate UK also funds health tech innovation; founders should monitor Innovate UK funding rounds.

NHS Contracting: While slower and more rigid than private contracts, NHS partnerships offer scale and cash flow stability. NHS procurement is centralised through NHS England and Integrated Care Systems; understanding procurement rules and timelines is critical for B2B health tech founders.

Competitive and Consolidation Dynamics

The 4.78% health sector growth is attracting larger players. Private equity-backed clinic operators (e.g., Spire, Circle, Ramsay Health Care) are aggressively acquiring independent practices. This consolidation is partly defensive (capturing market share as NHS waits grow) and partly operational (rolling out management systems, negotiating insurance contracts, achieving cost synergies).

For founder-operators, this creates both opportunity and pressure:

• Acquisition exit: Build a clinic or practice and sell to a larger operator. Multiples for profitable health practices range from 4-8x EBITDA, with growth uplifts for demonstrated user retention and revenue diversification.
• Organic scaling: Multi-unit operators (e.g., a network of physiotherapy clinics) can be built independently and then consolidated. This is capital-intensive but achieves scale without selling early.
• Niche specialisation: Avoid direct competition with consolidated players by specialising (e.g., women's health, musculoskeletal disorders, sports medicine). Niche clinics command higher margins and attract specialist referral networks.

Forward-Looking Analysis: Health Growth Beyond 2026

The trajectory is clear: health sector growth will likely persist for 5+ years. Key drivers:

NHS funding pressures: The Office for Budget Responsibility has forecast that NHS funding per capita will grow below historical trends through the 2030s. This structural underfunding will continue to push demand toward private provision.

Demographic tailwinds: The UK population is ageing. Healthcare demand from over-65s is projected to grow 40% by 2035. Private providers are better positioned than the constrained NHS to capture this growth.

Consumer willingness to pay: As NHS waits lengthen, patients' willingness to self-fund or use insurance increases. This has shifted from marginal phenomenon to mainstream behaviour, particularly in affluent regions.

Digital integration: Health tech is nascent. Founders building virtual consultations, AI-assisted diagnostics, and integrated patient records will capture significant value as the sector digitises.

However, risks exist. If the NHS receives a sudden funding injection (politically unlikely but possible), or if private insurance becomes heavily regulated (e.g., price caps), growth could moderate. Founders should stress-test their models against downside scenarios.

Additionally, the regional divergence seen in Hackney will persist. Founders must choose geography carefully: affluent regions with ageing populations (Kensington, Surrey, Oxfordshire) offer higher margins; younger, lower-income regions (parts of the North, Midlands) require lower-cost models but have less disposable income for private care.

Conclusion: Resilience Through Sector Selection

The juxtaposition of record UK business failures and robust health sector growth underscores a critical lesson for founders: macroeconomic conditions matter far less than sector dynamics. While the broader economy contracts, certain sectors—health care, particularly—expand by capturing displaced demand and demographic tailwinds.

Entrepreneurs evaluating startup ideas should ask: where is demand growing despite economic headwinds? What sectors are absorbing consumers and businesses displaced by consolidation or structural change? In 2026, health is a clear answer. Within health, clinical services, diagnostics, and health tech are particularly compelling.

Regional factors matter, but they are not destiny. Hackney's 3.44% failure rate coexists with thriving health clinics. The postcode lottery is real, but sector selection is more important than geography.

For founders in health, the window for capital deployment, team building, and market capture is open. NHS wait times are a gift—use them while they last.